Nixon Luc was Appointed as Director, Manufacturing Sciences and Technology (MSAT)- CMO Gene Therapy at Sarepta

Date of management change: March 15, 2022 

What Happened?

Cambridge, MA-based Sarepta Appointed Nixon Luc as Director, Manufacturing Sciences and Technology (MSAT)- CMO Gene Therapy

 

About the Company

Sarepta Therapeutics, headquartered in Cambridge, Massachusetts, is a commercial-stage biopharmaceutical company focused on the discovery and development of precision genetic medicine to treat rare diseases. Sarepta is at the forefront of precision genetic medicine, having built an impressive and competitive position in Duchenne muscular dystrophy (DMD) and more recently in Limb-girdle muscular dystrophy (LGMD), Charcot-Marie-Tooth (CMT) and CNS-related disorders, reaching a total of over 20 therapies in various stages of development. The Company`s programs span across several therapeutic modalities, including RNA, gene therapy and gene editing. Sarepta is poised to be the most meaningful precision genetic medicine company in the world and make a profound difference in the lives of patients suffering from rare neuromuscular diseases and other rare diseases.

 

About the Person

Nixon Luc is Director, Manufacturing Sciences and Technology (MSAT)- CMO Gene Therapy at Sarepta. Previously, Nixon held various senior HR leadership roles in the industry.

 

Info Source

News

 
 

Other IT executives who recently changed jobs as well: Davis James, Cade Cindy, Eschricht Laura, Norton Sandra, Bond Richard, McClearn Marisa, Godfrey Tim, Batelli Monica, Quarles Nadia, Prendergast Christopher, Michael Darragh

You can find the full directory of IT executives here.

How would you like to connect with 15,000+ IT executives in charge of $ millions in IT budgets? Find details here.